Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

DEVELOPMENT OF AN ANTIBODY: A REVIEW

  Authors

  Agrawal Hemant,  Saxena Swati,  Jain Sarang

  Keywords

Antigen, Antibody, Monoclonal Antibody, Hybridoma technique.

  Abstract


In a normal human body a balance environment is present. It is because of healthy immune system present in the body. Immune system is a complex network of cells and proteins which have ability to defend the infection acquired in body. As a result a healthy body has the ability to defeat the invading micro-organism. The invasion of microorganism is recognized with the help of developed antigens in body. In order to defend these foreign substances, antigens stimulates the production of antibodies. Monoclonal antibodies have approved applications in different types of critical and acute illness. It act as a promising treatment in the critical illness like cancer of any organ. Nowadays they are also used in treatment of infectious disorders like bacterial, viral and fungal infection. Antibodies can be prepared by different methods but large scale production of antibodies is done with the help of Hybridoma technology. In hybridoma technology clones of antibodies are prepared. Antigen firstly fused with B lymphocyte cell and then an hybrid cell is prepared in collaboration with myeloma cell to produce a defense mechanism in the form of antibodies. The main focus of writing this review is to access knowledge about what antibodies are and how they are developed for treatment of critical disorders in current scenario.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2110114

  Paper ID - 212366

  Page Number(s) - b13-b17

  Pubished in - Volume 9 | Issue 10 | October 2021

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Agrawal Hemant,  Saxena Swati,  Jain Sarang,   "DEVELOPMENT OF AN ANTIBODY: A REVIEW", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.9, Issue 10, pp.b13-b17, October 2021, Available at :http://www.ijcrt.org/papers/IJCRT2110114.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer